Table 1.
AMD, n = 145 |
DME, n = 26 |
RVO, n = 32 |
P-value | |
---|---|---|---|---|
Age, mean (SD) | 77.4 (7.4) | 61.8 (13.0) | 74.5 (9.9) | < 0.001a |
Gender, n (%) | ||||
Female, n (%) | 94 (64.8) | 7 (26.9) | 17 (53.1) | 0.001b |
Male, n (%) | 51 (35.2) | 18 (73.1) | 15 (46.9) | |
Visual acuity in best eye, ETDRS, median (IQR) | 80.0 (72–85) | 75.5 (65–85) | 82.5 (74–85) | 0.246c |
Visual acuity in best eye, LogMAR, median (IQR) | 0.1 (0.0–0.3) | 0.2 (0.0–0.4) | 0.0 (0.0–0.2) | |
Treatment duration in years, median (range) | 2 (0–11) | 2 (0–6) | 1 (0–5) | 0.014c |
Classes of municipalities | 0.749d | |||
Urban | 45 (31.0) | 6 (23.1) | 11 (34.4) | |
Intermediate | 56 (38.6) | 9 (34.6) | 9 (28.1) | |
Rural | 38 (26.2) | 9 (34.6) | 10 (31.3) | |
Peripheral | 6 (4.1) | 2 (7.7) | 2 (6.3) | |
Education level, n (%) | 0.007d | |||
Long-cycle higher education | 9 (6.3) | 5 (19.2) | 0 (0) | |
Medium-cycle higher education | 26 (18.1) | 4 (15.4) | 11 (34.4) | |
Short-cycle higher education | 37 (25.7) | 1 (3.8) | 7 (21.9) | |
Vocational | 36 (25.0) | 12 (46.2) | 8 (25.0) | |
Primary school | 36 (25.0) | 4 (15.4) | 6 (18.8) | |
Self perceived health, n (%) | 0.013d | |||
Good | 68 (47.2) | 15 (57.7) | 12 (37.5) | |
Average | 66 (45.8) | 5 (19.2) | 18 (56.3) | |
Poor | 10 (6.9) | 6 (23.1) | 2 (6.3) | |
Charlson’s Comorbidity Index, n (%) | < 0.001d | |||
None (0) | 85 (58.9) | 0 | 21 (65.6) | |
Low (1–2) | 50 (34.5) | 21 (80.8) | 11 (34.4) | |
Medium (3–4) | 9 (6.2) | 3 (11.5) | 0 | |
High (> 4) | 1 (0.7) | 2 (7.7) | 0 |
Abbreviations: AMD: Age-related macular degeneration; DME: Diabetic macular edema; RVO: Retinal vein occlusion; n: number; SD: standard deviation; EDTRS: Early Treatment Diabetic Retinopathy Study; LogMAR: Log of the minimum angle of resolution; IQR: interquartile range; aOne-way ANOVA; bChi square Test; cKruskal-Wallis Test; dFishers Exact Test